Definium Therapeutics Inc
(FRA:MMQ0)
€
38.6
+1.9 (+5.18%)
Market Cap: 5.15 Bil
Enterprise Value: 4.86 Bil
PE Ratio: 0
PB Ratio: 16.49
GF Score: 34/100 Definium Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 19, 2026 / 12:00PM GMT
Release Date Price:
€16.95
(-3.97%)
Unidentified Company Representative
Conference, Definium Therapeutics, represented by their CFO, Brandi Roberts. Brandi, thanks so much for being here.
Brandi Roberts
Definium Therapeutics Inc - Chief Financial Officer
Thanks so much for having us. Couldn't be more excited.
Questions & Answers
Unidentified Company Representative
Well, certainly exciting times at Definium these days with a lot of key data points coming up. And I was hoping we could maybe start with the next key data point that we're going to see, which is the major depressive disorder data for 120.
Brandi Roberts
Definium Therapeutics Inc - Chief Financial Officer
Yeah.
Unidentified Company Representative
I'm so used to MM.
So, we're coming up on the phase three eMERGE data any week now. And one of the questions we get most frequently is understanding the translatability from GAD and depressive symptoms in GAD, which in phase two, 120 did a really good job of
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot